TABLE 3.

Adjusted Hazard Ratios for Survival for Persons Diagnosed With AIDS Before and After the Introduction of Highly Active Antiretroviral Therapy: Chicago, 1993–2001

	Pre-HAART Era, 1993–1995		HAART Era, 1996–2001
Characteristic	HR (95% CI)	P	HR (95% CI)	P
Gender
Male (Ref)	1.00		1.00
Female	0.90 (0.79 , 1.03)	.12	1.20 (1.03, 1.40)	.02
Race/ethnicity
Non-Hispanic Black	1.18 (1.06, 1.31)	<.01	1.51 (1.26, 1.80)	<.01
Non-Hispanic White (Ref)	1.00		1.00
Hispanic	0.94 (0.81, 1.09)	>.05	1.22 (0.97, 1.53)	.10
Mode of transmission
Male-to-male sexual contact (Ref)	1.00		1.00
Injection drug use	0.94 (0.85, 1.04)	.22	1.30 (1.14, 1.49)	<.01
Heterosexual contact	0.89 (0.74, 1.08)	.25	0.94 (0.76, 1.16)	.54
Age at diagnosis, y
13–29 (Ref)	1.00		1.00
30–49	1.19 (1.05, 1.35)	.01	1.23 (1.02, 1.49)	.03
≥ 50	1.63 (1.38, 1.93)	<.01	2.28 (1.82, 1.49)	<.01
Opportunistic diseases
Pneumocystis carinii pneumonia (Ref)	1.00		1.00
Kaposi's sarcoma	1.11 (0.79, 1.55)	.55	0.99 (0.53, 1.85)	.97
Other	1.15 (0.99, 1.33)	.07	1.50 (1.22, 1.86)	.01
None	0.50 (0.43, 0.59)	<.01	0.55 (0.44, 0.69)	<.01

Note. HAART = highly active antiretroviral therapy; HR = hazard ratio; CI = confidence interval. Cox regression model used to adjust for gender, race/ethnicity, mode of transmission, age at diagnosis, and opportunistic diseases.